STARCOIN GROUP LTD

STARCOIN Group Ltd: Navigating Volatility & Biotech Growth Ahead

Discover how STARCOIN GROUP LTD’s gene‑testing and biotech strategy could reshape its future, despite current low stock price and negative P/E.

21/08/2026, 00:44

2 minutes to read

STARCOIN GROUP: Driving Gene‑Testing Innovation Amid Biotech Volatility

Discover how STARCOIN GROUP LTD is shaping the biotech world with gene‑testing, bio‑industrial products, and integrated healthcare services—an innovative force amid market volatility.

01/08/2026, 05:13

2 minutes to read

Starcoin Group’s Market Shift: Gene‑Testing, Bio‑Industrial Gains vs. Profit Challenges

Starcoin Group Ltd, a Hong Kong‑listed biotech and industrial distribution firm, faces volatile stock swings but aims to boost profitability by expanding gene‑testing and bio‑industrial services.

22/03/2026, 16:57

2 minutes to read

Starcoin Faces 68% Drop: HKEX Suspension Highlights Operational & Regulatory Gaps

Starcoin Group’s sharp 68% share plunge after HKEX suspension exposes operational woes and a bleak 52‑week low, urging investors to weigh regulatory risks.

05/02/2026, 16:13

2 minutes to read